SEC Info - Acelrx Pharmaceuticals Inc. - ‘8-K’ for 4/21/21

SEC Info℠

Home

Help

Please Sign In

Acelrx Pharmaceuticals Inc. – ‘8-K’ for 4/21/21 – ‘XML’

On: Tuesday, 4/27/21, at 4:02pm ET · For: 4/21/21 · Accession #: 1437749-21-9908 · File #: 1-35068

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/27/21  Acelrx Pharmaceuticals Inc.       8-K:1       4/21/21   11:152K                                   RDG Filings/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 7: R1          Document And Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- acrx20210426_8k_htm                 XML     12K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- acrx-20210421_def                XML     37K 
 4: EX-101.LAB  XBRL Labels -- acrx-20210421_lab                     XML     47K 
 5: EX-101.PRE  XBRL Presentations -- acrx-20210421_pre              XML     36K 
 2: EX-101.SCH  XBRL Schema -- acrx-20210421                         XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001437749-21-009908-xbrl      Zip     10K

‘XML’ — IDEA XML File — Filing Summary

This Document is an IDEA XML File.

<?xml version="1.0" encoding="windows-1252"?>

<FootnotesReported> false </FootnotesReported>

<TuplesReported> false </TuplesReported>

<IsDefault> false </IsDefault>

<HasEmbeddedReports> false </HasEmbeddedReports>

<LongName> 000 - Document - Document And Entity Information </LongName>

<ReportType> Sheet </ReportType>

<Role> http://www.acrx.com/20210421/role/statement-document-and-entity-information </Role>

<ShortName> Document And Entity Information </ShortName>

<MenuCategory> Cover </MenuCategory>

</Report>

<IsDefault> false </IsDefault>

<HasEmbeddedReports> false </HasEmbeddedReports>

<LongName> All Reports </LongName>

<ShortName> All Reports </ShortName>

</Report>

</MyReports>

</InputFiles>

</BaseTaxonomies>

<HasCalculationLinkbase> false </HasCalculationLinkbase>

</FilingSummary>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/15/21  Acelrx Pharmaceuticals Inc.       424B5                  1:461K                                   RDG Filings/FA
 8/18/21  Acelrx Pharmaceuticals Inc.       S-8         8/18/21    3:97K                                    RDG Filings/FA

↑Top

Filing Submission 0001437749-21-009908 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Acelrx Pharmaceuticals Inc. – ‘8-K’ for 4/21/21 – ‘XML’

On: Tuesday, 4/27/21, at 4:02pm ET · For: 4/21/21 · Accession #: 1437749-21-9908 · File #: 1-35068

Previous ‘8-K’: ‘8-K’ on 3/31/21 for 3/30/21 · Next: ‘8-K’ on / for 5/17/21 · Latest: ‘8-K’ on / for 4/19/24 · 2 References: By: Talphera, Inc. – ‘424B5’ on 11/15/21 By: Talphera, Inc. – ‘S-8’ on 8/18/21

Current Report — Form 8-KFiling Table of Contents

‘XML’ — IDEA XML File — Filing Summary

This Document is an IDEA XML File.

2 Subsequent Filings that Reference this Filing

Previous ‘8-K’: ‘8-K’ on 3/31/21 for 3/30/21 · Next: ‘8-K’ on / for 5/17/21 · Latest: ‘8-K’ on / for 4/19/24 · 2 References:

Current Report — Form 8-K
Filing Table of Contents